The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer
- 1 January 2001
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 30 (1) , 71-78
- https://doi.org/10.1002/1098-2744(200101)30:1<71::aid-mc1015>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and FinlandNew England Journal of Medicine, 2000
- Analysis of loss of heterozygosity andKRAS2 mutations in ovarian neoplasms: Clinicopathological correlationsGenes, Chromosomes and Cancer, 1997
- Hereditary Ovarian Cancer: Molecular Genetics and Clinical ImplicationsGynecologic Oncology, 1997
- Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancerMolecular Carcinogenesis, 1996
- Differences in Risk Factors for Epithelial Ovarian Cancer by Histologic Type: Results of a Case-Control StudyAmerican Journal of Epidemiology, 1996
- Human microsomal epoxide hydrolase: genetic poloymorphism and functional expression in vitro of amino acid variantsHuman Molecular Genetics, 1994
- The p53 tumor suppressor gene frequently is altered in gynecologic cancersAmerican Journal of Obstetrics and Gynecology, 1994
- Mortality in relation to smoking: 22 years' observations on female British doctors.BMJ, 1980
- Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxideNature, 1974
- Mammalian Epoxide Hydrases: Inducible Enzymes Catalysing the Inactivation of Carcinogenic and Cytotoxic Metabolites Derived from Aromatic and Olefinic CompoundsXenobiotica, 1973